Andrew Callos reports multiple 10b5-1 sales for CYTK (NASDAQ: CYTK)
Rhea-AI Filing Summary
Morgan Stanley Smith Barney LLC filed a Form 144 disclosing resale notices for Common stock related to multiple 10b5-1 sales attributed to Andrew Callos. The filing lists dated sales and per‑trade quantities with associated cash amounts, including
Positive
- None.
Negative
- None.
Insights
Routine resale notices under Rule 144 documenting several 10b5-1 sales.
The filing lists multiple executed sales of Common stock under prearranged 10b5-1 plans, with individual trades showing share counts and gross cash amounts (for example,
Cash‑flow treatment and any proceeds recipients are explicit in the trade lines; the filing does not state additional conditions or changes to ownership limits. Subsequent filings or Form 4s would be needed to update post‑transaction positions.
FAQ
What does CYTK's Form 144 disclose about Andrew Callos?
Are the transactions in CYTK's Form 144 open‑market sales or plan sales?
Does CYTK's Form 144 state who receives the sale proceeds?
Will CYTK’s Form 144 change reported ownership on its own?
Which dates and sizes are prominent in the CYTK Form 144 excerpt?